-+ 0.00%
-+ 0.00%
-+ 0.00%

ADMA Biologics Q4 Adj. EPS $0.21 Beats $0.18 Estimate, Sales $139.163M Miss $139.400M Estimate

Benzinga·02/25/2026 21:15:09
Listen to the news
ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.18 by 16.22 percent. This is a 53.57 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $139.163 million which missed the analyst consensus estimate of $139.400 million by 0.17 percent. This is a 18.39 percent increase over sales of $117.549 million the same period last year.